A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, ...

Fcα/μR also mediated primary B lymphocyte endocytosis of IgM-coated Staphylococcus ... we analyzed the cells by flow cytometry and a subpopulation of the Ba/F3 transfectants containing ...

This study provides a valuable new resource to investigate the molecular basis of the particular features characterizing the pipefish embryo. The authors found both unique and shared gene expression ...

Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice.

Jan. 23, 2025 — There's a downside to being a powerful alpha male -- at least if you're a baboon. Studies show that despite their high rank, the No. 1 males in baboon society are also some of ...

A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell.

Consequently, antimicrobial peptides exert direct effects against pathogens, and a number of cytokines/chemokines attract and activate other immune cells. Endocytosis of pathogens, production of ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell.

The management of Leishmania donova ni (LD), responsible for fatal visceral leishmaniasis (VL), faces increasing challenges due to rising drug-unresponsiveness, leading to increasing treatment ...

Daniel joined The EMBO Journal in 2015. Ieva received her PhD from the University of Göttingen where she worked on cell polarity and endocytosis in Drosophila in the lab of Andreas Wodarz. In 2011 she ...

Bone-marrow-derived multipotent progenitor stromal cells — or mesenchymal stem cells (MSCs) — are the common predecessors of cells of the mesenchymal lineage, such as bone, cartilage and fat ...

Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ('CSPC') (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has ...